Special Needs

Articles

...change for some patients with a new drug called Kalydeco (generic name ivacaftor), which has just been...approved by the Food and Drug Administration (FDA). Kalydeco targets a genetic mutation in four to five percent...simply treating the symptoms. The FDA fast-tracked Kalydeco and approved it in only three months, given its...